AstraZeneca Licenses Two Nektar Compounds

Monday, September 21, 2009 - 14:28 in Mathematics & Economics

Pharmaceuticals: $125 Million deal puts spotlight on drug-polymer conjugates.

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net